ClinConnect ClinConnect Logo
Search / Trial NCT05632120

Investigation of Impairments in Body Functions and Structures, Activities and Participation Restrictions in COPD

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 20, 2022

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

To investigate the impairments in body functions and structures, activities and participation restrictions according to the International Classification of Functioning, Disability and Health (ICF) framework in patients with COPD, fifty patients with COPD will be included.

The Modified Medical Research Council Dyspnea (MMRC) scale and Six-Minute Walking Test (6MWT) will be used for evaluating the how dyspnea limits the patients' daily activities and functional capacity, respectively. Isometric muscle strength will be measured with a handheld dynamometer of quadriceps femoris. Fear of fallin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. stable disease (no severe exacerbations in the prior 3 months)
  • 2. ability to walk independently
  • 3. ability to read and write in Turkish
  • 4. able to follow simple instructions
  • 5. no pathology in visual ability and hearing
  • Exclusion Criteria:
  • 1. a history of specific balance problems (i.e., diagnosed vestibular or neurological disorder)
  • 2. severe musculoskeletal, neurological or cardiovascular disorders that limit mobility
  • 3. use of medication(s) that may increase the risk of falls
  • 4. participate in pulmonary rehabilitation in the lasts six months

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, , Turkey

Istanbul, Fatih/İstanbul, Turkey

Patients applied

0 patients applied

Trial Officials

Tansu Birinci, PT, PhD

Principal Investigator

Istanbul University - Cerrahpasa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials